This invention relates to the field of
pharmaceutical technology, specifically disclosing an etodoxa acid
small molecule hydrogel and its preparation method. The hydrogel is prepared by mixing etodoxa acid with three
small molecule ligands (glucamine,
arginine, and
lysine). The morphological characteristics, thermodynamic properties, intermolecular interactions, and
dissolution effects of the hydrogel were verified using SEM, rheological testing, DSC, XRPD, FTIR, and
dissolution experiments. The preparation method is simple, involving mixing etodoxa acid with the
small molecule ligands, adding a small amount of deionized water, and shaking. The resulting hydrogel significantly improves the
solubility and
dissolution / release rate of etodoxa acid. Compared to etodoxa acid crystals, the hydrogel exhibits significantly better
solubility, dissolution / release rate in water than individual crystalline drugs or their physical mixtures, demonstrating the potential to improve the
bioavailability of etodoxa acid. This provides a new formulation strategy for addressing the
solubility defects of poorly soluble drugs and for
combination drug use.